Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,405.20
(
-2.38%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
0.00%
)
Bitcoin
66,294.30
(
-0.07%
)
News Focus
News Focus

Replies to post #198796 on Biotech Values

Replies to #198796 on Biotech Values
icon url

DewDiligence

01/05/16 6:33 PM

#198797 RE: zipjet #198796

Short answer: no. Less consequential than the Simtuzumab program for NASH, and even that program is iffy, IMO (#msg-109653984, bottom).